Tizhong Shan1,2, Pengpeng Zhang3,4, Qinyang Jiang3,5, Yan Xiong3, Yizhen Wang6, Shihuan Kuang7,8. 1. College of Animal Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, 310058, People's Republic of China. tzshan@zju.edu.cn. 2. Department of Animal Sciences, Purdue University, 901 West State Street, West Lafayette, IN, 47907, USA. tzshan@zju.edu.cn. 3. Department of Animal Sciences, Purdue University, 901 West State Street, West Lafayette, IN, 47907, USA. 4. College of Life Sciences, Xinyang Normal University, Xinyang, People's Republic of China. 5. College of animal science and technology, Guangxi University, Nanning, People's Republic of China. 6. College of Animal Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, 310058, People's Republic of China. 7. Department of Animal Sciences, Purdue University, 901 West State Street, West Lafayette, IN, 47907, USA. skuang@purdue.edu. 8. Purdue University Center for Cancer Research, West Lafayette, IN 47907, USA. skuang@purdue.edu.
Abstract
AIMS/HYPOTHESIS: The in vivo role of mechanistic target of rapamycin (mTOR) in the development and function of adipose tissue, especially brown adipose tissue (BAT), is not well understood. Here, we aimed to assess the effect of mTOR (also known as Mtor) knockout on adipose tissues and systemic energy metabolism. METHODS: We generated adipocyte-specific mTOR-knockout mice (Adipoq-mTOR) by crossing adiponectin-Cre (Adipoq-Cre) mice with mTOR (flox/flox) mice. The mice were then subjected to morphological, physiological (indirect calorimetry, glucose and insulin tolerance tests) and gene expression analyses to determine the role of mTOR in adipose tissues. RESULTS: We provide in vivo evidence that mTOR is essential for adipose tissue development and growth. Deletion of mTOR decreased the mass of both BAT and white adipose tissues (WAT) and induced browning of WAT. In addition, ablation of mTOR in adipose tissues caused insulin resistance and fatty liver in the Adipoq-mTOR mice. Furthermore, mTOR was required for adipocyte differentiation in vivo and activation of PPARγ ameliorated the differentiation deficiency of the mTOR-null adipocytes. CONCLUSIONS/ INTERPRETATION: Our findings demonstrate that mTOR is a critical regulator of adipogenesis and systemic energy metabolism. Our study provides key insights into the role of mTOR in adipose tissues; such knowledge may facilitate the development of novel strategies with which to treat obesity and related metabolic diseases.
AIMS/HYPOTHESIS: The in vivo role of mechanistic target of rapamycin (mTOR) in the development and function of adipose tissue, especially brown adipose tissue (BAT), is not well understood. Here, we aimed to assess the effect of mTOR (also known as Mtor) knockout on adipose tissues and systemic energy metabolism. METHODS: We generated adipocyte-specific mTOR-knockout mice (Adipoq-mTOR) by crossing adiponectin-Cre (Adipoq-Cre) mice with mTOR (flox/flox) mice. The mice were then subjected to morphological, physiological (indirect calorimetry, glucose and insulin tolerance tests) and gene expression analyses to determine the role of mTOR in adipose tissues. RESULTS: We provide in vivo evidence that mTOR is essential for adipose tissue development and growth. Deletion of mTOR decreased the mass of both BAT and white adipose tissues (WAT) and induced browning of WAT. In addition, ablation of mTOR in adipose tissues caused insulin resistance and fatty liver in the Adipoq-mTORmice. Furthermore, mTOR was required for adipocyte differentiation in vivo and activation of PPARγ ameliorated the differentiation deficiency of the mTOR-null adipocytes. CONCLUSIONS/ INTERPRETATION: Our findings demonstrate that mTOR is a critical regulator of adipogenesis and systemic energy metabolism. Our study provides key insights into the role of mTOR in adipose tissues; such knowledge may facilitate the development of novel strategies with which to treat obesity and related metabolic diseases.
Authors: Kristin I Stanford; Roeland J W Middelbeek; Kristy L Townsend; Ding An; Eva B Nygaard; Kristen M Hitchcox; Kathleen R Markan; Kazuhiro Nakano; Michael F Hirshman; Yu-Hua Tseng; Laurie J Goodyear Journal: J Clin Invest Date: 2012-12-10 Impact factor: 14.808
Authors: Larissa S Carnevalli; Kouhei Masuda; Francesca Frigerio; Olivier Le Bacquer; Sung Hee Um; Valentina Gandin; Ivan Topisirovic; Nahum Sonenberg; George Thomas; Sara C Kozma Journal: Dev Cell Date: 2010-05-18 Impact factor: 12.270
Authors: Jessica M Olsen; Masaaki Sato; Olof S Dallner; Anna L Sandström; Didier F Pisani; Jean-Claude Chambard; Ez-Zoubir Amri; Dana S Hutchinson; Tore Bengtsson Journal: J Cell Biol Date: 2014-11-10 Impact factor: 10.539
Authors: Elise Jeffery; Ryan Berry; Christopher D Church; Songtao Yu; Brett A Shook; Valerie Horsley; Evan D Rosen; Matthew S Rodeheffer Journal: Adipocyte Date: 2014-06-27 Impact factor: 4.534
Authors: Kevin Y Lee; Steven J Russell; Siegfried Ussar; Jeremie Boucher; Cecile Vernochet; Marcelo A Mori; Graham Smyth; Michael Rourk; Carly Cederquist; Evan D Rosen; Barbara B Kahn; C Ronald Kahn Journal: Diabetes Date: 2013-01-15 Impact factor: 9.461
Authors: Oded Volovelsky; Thi Nguyen; Alison E Jarmas; Alexander N Combes; Sean B Wilson; Melissa H Little; David P Witte; Eric W Brunskill; Raphael Kopan Journal: Proc Natl Acad Sci U S A Date: 2018-05-21 Impact factor: 11.205
Authors: Anna N Senko; Rupert W Overall; Jan Silhavy; Petr Mlejnek; Hana Malínská; Martina Hüttl; Irena Marková; Klaus S Fabel; Lu Lu; Ales Stuchlik; Robert W Williams; Michal Pravenec; Gerd Kempermann Journal: PLoS Genet Date: 2022-04-04 Impact factor: 6.020